The IRS continues to provide guidance as part of its ongoing efforts to implement the CARES Act and respond to the economic challenges arising from the COVID-19 pandemic. As part of our continuing coverage of COVID-19 relief, this Tax Special Alert highlights Notice 2020-35, which was issued on May 28, 2020.

The New York State Legislature passed a bill that would amend the administrative code of the city of New York and decouple from certain amendments made by the CARES Act (Pub. L. 116-136) to the Internal Revenue Code (“IRC”) for the New York City (“NYC”) unincorporated business corporation tax (“UBT”), general corporation tax (“GCT”), banking tax (“Bank Tax”) and business corporation tax (“BCT”). The bill needs to be approved by Governor Andrew M. Cuomo to become law.

Accelerated sale of a casual diner to a connected party via pre-pack.

Carve-out of loss making division and accelerated sale to a UK based PE house. ​

On Friday 29 May, Rishi Sunak made further announcements on the Coronavirus Job Retention Scheme support available to employers from 1 July 2020 onwards.

As Private Equity sponsored companies pivot to recovery coming out of the COVID-19 crisis, the chance to re-design business models and business processes are a hidden benefit.

Indonesia SMEs have the opportunity to take four key strategic steps that help bolster their businesses against the uncertainty now, and ensure they emerge in a strong position during the post COVID-19 recovery.

Yesterday, the IRS released new questions and answers (Q&As) without much fanfare providing information for C corporations that carry back net operating losses to pre-TCJA years in which the alternative minimum tax (AMT) applies.

Webinar: Discussion focused around digital and data-driven healthcare outreach and delivery, indigenous ecosystem, consolidation of back-end operations and mitigation of value chain risks

In this paper, we explore the scale of first mover advantage in generic pharmaceuticals and the methods behind quantifying the value of being first generic to market, or the loss when being prevented from doing so.

The spread of COVID-19 has presented the global healthcare and life sciences sectors with unprecedented challenges. At Alvarez & Marsal, we are leveraging our specialisms in operational transformation, transaction advisory and supply chain to guide leading enterprises through difficult times.

Impact of the COVID-19 VAT deferral on Bad Debt Relief (BDR) claim

In this webinar, A&M Managing Director Paul Rundell discussed smart investing in the U.S. distressed healthcare sector.

BEA is Requiring US Persons to Complete Questionnaires on Foreign Investments